![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Friday, July 01, 2022 12:43:25 PM
Regarding the Countersuit by FTH/Fluent against CIGN. CIGN's response to their claims.
They claim the product produced at the property was saleable.
The product passed all tests performed by the ACS Laboratory, which included analyses of heavy metals, mycotoxins and pesticides.
The test results are attached as exhibit A.
They deny all other allegations made.
Exhibit A is ACS Laboratory Certificate of Analysis on 04-22-21. Passed all tests.
Another ACS Lab Report dated 09-28-21. All tests passed.
Recent CATV News
- Category V Biotech, Inc. Announces Letter of Intent to Acquire Genetic Networks, Expanding into Biotechnology Sector • InvestorsHub NewsWire • 05/15/2024 12:00:00 PM
- Progress Report February 13 2024 • InvestorsHub NewsWire • 02/13/2024 04:25:04 PM
- Letter to Shareholders from 4Cable TV International, Inc. • InvestorsHub NewsWire • 01/05/2024 02:00:00 PM
- Small Cap Recipient of Military Drone Technology • InvestorsHub NewsWire • 11/20/2023 01:14:45 PM
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM
VAYK Exited Caribbean Investments for $320,000 Profit • VAYK • Jun 27, 2024 9:00 AM
North Bay Resources Announces Successful Flotation Cell Test at Bishop Gold Mill, Inyo County, California • NBRI • Jun 27, 2024 9:00 AM
Branded Legacy, Inc. and Hemp Emu Announce Strategic Partnership to Enhance CBD Product Manufacturing • BLEG • Jun 27, 2024 8:30 AM
POET Wins "Best Optical AI Solution" in 2024 AI Breakthrough Awards Program • POET • Jun 26, 2024 10:09 AM
HealthLynked Promotes Bill Crupi to Chief Operating Officer • HLYK • Jun 26, 2024 8:00 AM